London School of Hygiene and Tropical Medicine, London WCIE 7HT.
BMJ. 2010 Mar 30;340:c1350. doi: 10.1136/bmj.c1350.
To assess the performance of WHO's "Guidelines for care at the first-referral level in developing countries" in an area of intense malaria transmission and identify bacterial infections in children with and without malaria.
Prospective study.
District hospital in Muheza, northeast Tanzania.
Children aged 2 months to 13 years admitted to hospital for febrile illness.
Sensitivity and specificity of WHO guidelines in diagnosing invasive bacterial disease; susceptibility of isolated organisms to recommended antimicrobials.
Over one year, 3639 children were enrolled and 184 (5.1%) died; 2195 (60.3%) were blood slide positive for Plasmodium falciparum, 341 (9.4%) had invasive bacterial disease, and 142 (3.9%) were seropositive for HIV. The prevalence of invasive bacterial disease was lower in slide positive children (100/2195, 4.6%) than in slide negative children (241/1444, 16.7%). Non-typhi Salmonella was the most frequently isolated organism (52/100 (52%) of organisms in slide positive children and 108/241 (45%) in slide negative children). Mortality among children with invasive bacterial disease was significantly higher (58/341, 17%) than in children without invasive bacterial disease (126/3298, 3.8%) (P<0.001), and this was true regardless of the presence of P falciparum parasitaemia. The sensitivity and specificity of WHO criteria in identifying invasive bacterial disease in slide positive children were 60.0% (95% confidence interval 58.0% to 62.1%) and 53.5% (51.4% to 55.6%), compared with 70.5% (68.2% to 72.9%) and 48.1% (45.6% to 50.7%) in slide negative children. In children with WHO criteria for invasive bacterial disease, only 99/211(47%) of isolated organisms were susceptible to the first recommended antimicrobial agent.
In an area exposed to high transmission of malaria, current WHO guidelines failed to identify almost a third of children with invasive bacterial disease, and more than half of the organisms isolated were not susceptible to currently recommended antimicrobials. Improved diagnosis and treatment of invasive bacterial disease are needed to reduce childhood mortality.
评估世界卫生组织(WHO)“发展中国家基层医疗保健指南”在疟疾高度传播地区的应用效果,并确定有和无疟疾儿童中的细菌感染情况。
前瞻性研究。
坦桑尼亚东北部穆赫扎区医院。
因发热而住院的 2 月龄至 13 岁儿童。
WHO 指南诊断侵袭性细菌病的敏感性和特异性;分离出的细菌对推荐使用的抗菌药物的敏感性。
在一年期间,共纳入 3639 名儿童,其中 184 名(5.1%)死亡;2195 名(60.3%)血涂片阳性为恶性疟原虫,341 名(9.4%)患有侵袭性细菌病,142 名(3.9%)HIV 血清阳性。血涂片阳性儿童中侵袭性细菌病的发生率低于血涂片阴性儿童(100/2195,4.6%)[142/1444,10.0%)]。非伤寒沙门氏菌是最常分离到的细菌(52/100 [52%]),而在血涂片阴性儿童中为 108/241(45%)。侵袭性细菌病患儿的死亡率显著高于无侵袭性细菌病患儿(58/341,17%)[126/3298,3.8%](P<0.001),而且这一结果与恶性疟原虫的存在与否无关。在血涂片阳性儿童中,WHO 标准诊断侵袭性细菌病的敏感性和特异性分别为 60.0%(95%置信区间为 58.0%至 62.1%)和 53.5%(51.4%至 55.6%),而在血涂片阴性儿童中分别为 70.5%(68.2%至 72.9%)和 48.1%(45.6%至 50.7%)。在符合 WHO 侵袭性细菌病标准的患儿中,只有 211 例(47%)分离的细菌对抗推荐的首选用药敏感。
在疟疾高度传播地区,目前的 WHO 指南未能识别近三分之一的侵袭性细菌病患儿,而且超过一半的分离细菌对抗目前推荐的抗菌药物不敏感。需要改善侵袭性细菌病的诊断和治疗,以降低儿童死亡率。